Share Facebook Twitter Email This exposé reveals that 37% of all industry funding goes to 1% of medical oncologists, an elite group composed almost exclusively of leaders of national organizations, hospitals, editorial boards, and clinical practice guidelines. Citation(s) Wright, J Clin Oncol 2022 Controversial